Teknova to Participate in Upcoming Investor Conference
Alpha Teknova, a provider of critical reagents for drug therapies and molecular diagnostics, will participate in the William Blair 42nd Annual Growth Stock Conference from June 6 to 9, 2022, in Chicago, IL. CEO Stephen Gunstream and CFO Matt Lowell will present on June 8 at 4:20 p.m. ET, discussing the company’s highlights, product portfolio, and market opportunities. A live audio webcast will be available on their Investor Relations website for 90 days post-event.
- None.
- None.
HOLLISTER, Calif., May 25, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference:
William Blair 42nd Annual Growth Stock Conference
June 6 – 9, 2022
Chicago, IL
Stephen Gunstream, President and Chief Executive Officer, and Matt Lowell, Chief Financial Officer, will present at 4:20 p.m. ET, on Wednesday, June 8, 2022. Gunstream and Lowell plan to discuss Company highlights, their product portfolio, market trends, key growth drivers, and long-term market opportunities.
The live audio webcast for this conference may be accessed from the Investor Relations section of the Company’s website: https://ir.teknova.com/. The webcast will be available on the Company’s website for approximately 90 days after the event.
About Teknova
Teknova is expediting clinical breakthroughs in life sciences by providing custom products and reagents for drug therapies, novel vaccines, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high-quality, custom, made-to-order products with short turnaround times and at scale across all stages of development, including commercialization.
FAQ
What is the date and location of the William Blair 42nd Annual Growth Stock Conference for TKNO?
Who will present at the TKNO conference and when?
How can I access the webcast for TKNO's conference presentation?
What topics will be discussed during TKNO's presentation at the investor conference?
What does Teknova specialize in?
